GSK PLC (GSK)
44.67
+0.53
(+1.20%)
USD |
NYSE |
May 09, 16:00
44.91
+0.24
(+0.54%)
Pre-Market: 04:56
GSK SG&A Expense (Quarterly): 2.647B for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.647B |
December 31, 2023 | 3.326B |
September 30, 2023 | 2.907B |
June 30, 2023 | 2.839B |
March 31, 2023 | 2.605B |
December 31, 2022 | 2.867B |
September 30, 2022 | 2.420B |
June 30, 2022 | 2.597B |
March 31, 2022 | 2.431B |
December 31, 2021 | 2.956B |
September 30, 2021 | 2.315B |
June 30, 2021 | 2.361B |
March 31, 2021 | 3.346B |
December 31, 2020 | -1.131B |
September 30, 2020 | 3.449B |
June 30, 2020 | 3.359B |
March 31, 2020 | 3.738B |
December 31, 2019 | 4.435B |
September 30, 2019 | 3.563B |
June 30, 2019 | 3.329B |
March 31, 2019 | 3.227B |
December 31, 2018 | 3.371B |
September 30, 2018 | 3.292B |
June 30, 2018 | 3.348B |
March 31, 2018 | 3.213B |
Date | Value |
---|---|
December 31, 2017 | 3.364B |
September 30, 2017 | 3.021B |
June 30, 2017 | 3.041B |
March 31, 2017 | 3.037B |
December 31, 2016 | 3.368B |
September 30, 2016 | 3.011B |
June 30, 2016 | 3.123B |
March 31, 2016 | 3.134B |
December 31, 2015 | 3.789B |
September 30, 2015 | 3.050B |
June 30, 2015 | 3.892B |
March 31, 2015 | 3.373B |
December 31, 2014 | 3.491B |
September 30, 2014 | 3.361B |
June 30, 2014 | 3.458B |
March 31, 2014 | 3.261B |
December 31, 2013 | 3.561B |
September 30, 2013 | 3.076B |
June 30, 2013 | 3.404B |
March 31, 2013 | 3.231B |
December 31, 2012 | 3.549B |
September 30, 2012 | 3.531B |
June 30, 2012 | 3.483B |
March 31, 2012 | 3.365B |
December 31, 2011 | 3.413B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
-1.131B
Minimum
Dec 2020
4.435B
Maximum
Dec 2019
2.818B
Average
2.887B
Median
SG&A Expense (Quarterly) Benchmarks
AstraZeneca PLC | 4.63B |
Novo Nordisk A/S | 2.099B |
Pfizer Inc | 3.495B |
Sanofi SA | 2.830B |
Moderna Inc | 274.00M |